Stay updated on Pembrolizumab in MM Residual Disease Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in MM Residual Disease Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in MM Residual Disease Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    Added a new MedlinePlus Genetics topic: Multiple myeloma, expanding core genetics coverage with a specific medical condition.
    Difference
    0.2%
    Check dated 2025-10-11T15:23:34.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    - Added a government-operating-status notice and confirmation that the NIH Clinical Center is open, plus a version update to v3.2.0. - Removed a MedlinePlus Genetics topic: multiple myeloma (v3.1.0) from the topics.
    Difference
    3%
    Check dated 2025-10-04T12:27:37.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    Terminology updated from Plasma cell myeloma to Multiple myeloma and version bumped from v3.0.2 to v3.1.0. The change mainly reflects standard naming and versioning; no other substantive content changes are indicated.
    Difference
    0.1%
    Check dated 2025-09-27T08:08:51.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    Updated to Revision: v3.0.2 and removed 'Back to Top'.
    Difference
    0.1%
    Check dated 2025-09-13T01:46:26.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.
    Difference
    0.1%
    Check dated 2025-09-05T19:59:03.000Z thumbnail image
  7. Check
    55 days ago
    Change Detected
    Summary
    The web page has undergone significant changes, including the addition of specific facility names and locations related to plasma cell myeloma, while also removing previous mentions of multiple myeloma and related terms.
    Difference
    2%
    Check dated 2025-08-29T18:56:49.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in MM Residual Disease Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in MM Residual Disease Clinical Trial page.